CrossRef Formic acid released by intratumoral Bacteroides thetaiotaomicron facilitates combinational therapy of Apatinib and aPD-1 in hepatocellular carcinoma Jiongjiong Lu, Feiling Feng, Chunlei Li, Ziqing Yu, Tingting Zhang, Anchang Liu, Qingxiang Gao, Zhizhen Li, Li Luo, Xuemei Guan, Yanxiao Xiang, Hao Zhuang Acta Pharmaceutica Sinica B .2026;[Epub] CrossRef Current advances and future directions in the management of HBV-related hepatocellular carcinoma Andrew F Ibrahim, Julie Sang, Pojsakorn Danpanichkul, Kwanjit Duangsonk, Ju Dong Yang, Thomas A Kerr, Amit G Singal Gastroenterology Report .2026;[Epub] CrossRef Polyporusterone E, a Key Component of Polyporus umbellatus, as a Potential Regulator of CHEK 1 in Liver Cancer: Integrated Network Pharmacology, Bioinformatics, and Experimental Validation Xinhui Huang, Ruichen Gao, Xinran Yu, Zheng Feng, Qingxia Wang, Xiaotian Wu, Shulu Zhang, Yinze Zhong, Yeqing Xu, Meiting Jiang, Chunli Gan, Xiaotong Wang, Shuang Jiang, Chunjuan Yang International Journal of Molecular Sciences .2026

As the weight loss drug landscape evolves, understanding their full potential as they continue to come onto the market requires clear government mandates to ensure these emerging treatments enter a system that is clinically ready and equipped to support patients safely with wraparound care alongside the drugs
What to Expect from Peptide Therapy Your journey begins with a comprehensive consultation to evaluate your health goals, injury history, and wellness needs
2006 Apr;27(4):921-30